Demystifying a Plaque on the Leg - A Case of Granulomatous Pyoderma Gangrenosum
Indian Dermatology Online Journal · 2026-11 · 17 (6) · 845-847
DOI: 10.4103/idoj.idoj_910_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Dermatology Online Journal, online erschienen am 30.04.2026. Verfasst von Dhruvika Tiwari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprosy, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Dear Editor, Granuloma in the skin can arise from a very diverse background; infective and non-infective conditions may present with granulomas on histopathology. While leprosy, cutaneous tuberculosis, cutaneous leishmaniasis, and subcutaneous mycoses account for a vast majority of infective causes revealing granulomatous pathology, common non-infective causes include sarcoidosis, granuloma annulare, and foreign body granulomas.[1] Pyoderma gangrenosum (PG) rarely presents with a granuloma on histopathological examination. Here, we present a case of superficial pyoderma gangrenosum, which revealed granulomatous inflammation. A 63-year-old fisherwoman presented with an asymptomatic skin lesion on the right leg for 2 years. It started as a small red lesion that gradually increased in size. She had a history of trauma at the same site and had taken both oral and topical ayurvedic treatment earlier. She was a known case of rheumatoid arthritis diagnosed 10 years previously, and was receiving oral methotrexate 10 mg once weekly, hydroxychloroquine 200 mg twice daily, and prednisolone 5mg daily. Cutaneous examination revealed a solitary vegetative plaque measuring 8 cm × 6 cm in size with areas of crusting and superficial ulceration on the medial aspect of the right leg [Figure 1a].Figure 1: (a) A solitary vegetative 8 cm × 6 cm plaque with crusting and superficial ulceration on the medial aspect of the right leg. (b) Few crusted plaques with peripheral depigmentation and hyperpigmentation on the right leg after 3 months of treatmentA provisional diagnosis of infective cutaneous granulomatosis (chromoblastomycosis or lupus vulgaris) was considered. The fungal culture and scraping were negative. An incisional biopsy was performed, which revealed pseudoepitheliomatous hyperplasia with granulomatous inflammation; however, acid-fast bacilli were not identified [Figures 2 and 3]. Based on the chronicity and clinical features of the lesion, negative staining and cultures for fungi and bacteria, histopathological findings consistent with cutaneous granulomatous inflammation without any malignant changes, and fulfillment of the diagnostic criteria proposed by Su et al.,[2] a final diagnosis of granulomatous pyoderma gangrenosum was established. The patient was started on oral colchicine 0.5 mg twice daily for a total duration of 7 months, resulting in significant clinical improvement and flattening of the lesion [Figure 1b].Figure 2: Photomicrograph showing ulcerated epidermis with hyperkeratosis, parakeratosis, focal hypergranulosis and irregularly arranged elongated and acanthotic bulbous rete ridges with intraepithelial infiltrates. Dermal edema with dense mixed inflammatory infiltrate with few granulomas and haemorrhage (Hematoxylin and eosin, 20x)Figure 3: Large cells with abundant cytoplasm, nuclear pleomorphism, ill-defined clusters of neutrophils with stromal edema (Hematoxylin and eosin, 400x)PG is a reactive non-infectious disease falling under the broad category of neutrophilic dermatoses. It is typically a diagnosis of exclusion, confirmed after ruling out other cutaneous ulcerating diseases. Many clinical phenotypes–classic, peristomal, pustular, bullous, vegetative, extracutaneous, and atypical- have been reported, with the most common being the classic ulcerative PG.[3,4] It usually presents as a large, painful ulcer with characteristic greyish, undermined edges and a necrotic, purulent base. The ulcers tend to heal with atrophic cribriform scarring.[4] Superficial granulomatous or vegetative PG is a rare variant that presents with large, erythematous plaques and shallow ulcers with elevated edges and/or sinus formation.[4] It may resemble conditions like pyoderma vegetans, blastomycosis-like pyoderma, dermatitis artefacta, and sometimes infectious granulomatous conditions.[5] On histopathology, it shows pseudoepitheliomatous hyperplasia mimicking squamous cell carcinoma, and dense dermal infiltrate composed of histiocytes and neutrophils with or without “three-layered granuloma” configuration, which is seen in classic cases.[3,5] It is usually not associated with any underlying conditions or other systemic symptoms. However, in a review of 46 cases, 18% of patients had associated chronic renal failure, diabetes mellitus, rheumatoid arthritis, chronic lymphocytic leukemia, sarcoidosis, vitiligo, and IgA paraproteinemia.[4,5] Langan et al. described a case of rheumatoid arthritis coexisting with granulomatous PG.[4] According to Wilson-Jones and Winkelmann, this variant has an indolent course and can resolve without the use of oral steroid therapy. Treatment includes the use of corticosteroids (oral, topical, or intralesional), minocycline, dapsone, cyclosporine, clofazimine, thalidomide, tacrolimus, sodium cromoglycate, and hyperbaric oxygen.[5,6] It has a favorable prognosis in contrast to the much aggressive presentation of classic ulcerative PG. This case report highlights the clinicopathological features of superficial granulomatous PG and its ability to mimic other infectious granulomatosis. It should be considered as a differential in a patient presenting with cutaneous ulcerating dermatosis, especially when infective etiologies are ruled out. It has a favorable prognosis, and the line of treatment is conservative, including the use of low-dose corticosteroids, unlike classic PG, which requires much aggressive treatment.[4] Authors’ contributions We confirm that all authors have read and approved the manuscript for submission. All authors meet authorship criteria, and the manuscript represents honest work. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that her name and initial will not be published and due efforts will be made to conceal her identity, but anonymity cannot be guaranteed. Financial support and sponsorship Nil. Conflicts of interest One of the authors is a member of the editorial board of the journal. The manuscript was subject to journal’s standard procedure and peer review was held independently of the editor or their research group. Use of artificial intelligence (AI) The preparation of this manuscript was carried out entirely by the authors without the use of artificial intelligence technologies.
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Leprosy, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.
- Pathology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.
ORCID-Profile: Dhruvika Tiwari, Swati Sharma, Raghavendra Rao
Zitieren
APA
Tiwari, D., Sharma, S., & Rao, R. (2026). Demystifying a Plaque on the Leg - A Case of Granulomatous Pyoderma Gangrenosum. Indian Dermatology Online Journal, 17(6), 845-847. https://doi.org/10.4103/idoj.idoj_910_25
Vancouver
Tiwari D, Sharma S, Rao R. Demystifying a Plaque on the Leg - A Case of Granulomatous Pyoderma Gangrenosum. Indian Dermatology Online Journal. 2026;17(6):845-847. doi:10.4103/idoj.idoj_910_25
BibTeX
@article{Tiwari2026,
author = {Tiwari, Dhruvika and Sharma, Swati and Rao, Raghavendra},
title = {Demystifying a Plaque on the Leg - A Case of Granulomatous Pyoderma Gangrenosum},
journal = {Indian Dermatology Online Journal},
year = {2026},
volume = {17},
number = {6},
pages = {845--847},
doi = {10.4103/idoj.idoj_910_25}
}
EUVIMED